Healthy Subject
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1,Healthy subjects, males and females, aged 20 or over, and no limit 2,Subjects who have received a sufficient explanation of the purpose and content of the research, have a clear understanding, and voluntarily express their intent to participate, can provide written consent to join the research
Exclusion criteria
Exclusion criteria: 1,Subjects currently undergoing medical treatment or therapy, including medication and traditional herbal medicine, for any form of illness or condition. 2,Subjects undergoing dietary and exercise therapy under the supervision of a doctor 3,Subjects with a current or past history of severe medical conditions. 4,Subjects who regularly consume over-the-counter pharmaceuticals, quasi-drugs, supplements, specific health-use foods, and foods with function claims. (Those who can stop taking them after obtaining consent are eligible to participate.) 5,Subjects with current or past history of medication allergies or food allergies 6,Subjects who have donated blood components or 200ml of whole blood within 1 month from the start of this study 7,Subjects who have donated 400 ml of whole blood within 4 months from the start of this study 8,Subjects who have participated or are currently participating in other clinical trials or clinical research within one month before obtaining consent, or those who plan to participate during the study period 9,Currently pregnant or breastfeeding subjects, or those who are planning to become pregnant during the study period. 10,Subject who regularly drink a lot of alchol (equivalent to 60g/day in terms of alcohol content 11,Subjects with extremely irregular eating habits, shift workers, and subjects with an irregular life rhythm, such as those working night shifts 12,Subjets who are judged by the principal investigator to be unsuitable for participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| physical examination,body weight,BMI,vital signs,clinical examination,Adverse event,Concomitant symptoms | — |
Countries
Japan
Contacts
Seishukai Clinic Clinical trial office